News
As of Friday, Aug. 1, the moon phase is First Quarter. This phase occurs when the moon is half lit up. NASA confirms this, ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
A phase 3 trial of Spine BioPharma’s chronic low back pain candidate has missed its primary endpoint. But, with the biotech pinning the failure on a “very high sham control response,” management plans ...
Joseph Paintsil scores a pair of goals and Marco Reus adds another in the second half as the Galaxy get off to a strong start ...
(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...
TransAlta Corporation ( NYSE: TAC) Q2 2025 Earnings Conference Call August 1, 2025 11:00 AM ET Joel E. Hunter - Executive VP of Finance & CFO John Harry Kousinioris - President, CEO & Director ...
The Greater Williamson Road Area Business Association has opened applications for phase two of its facade grant program. The initiative offers funding to help eligible Roanoke businesses upgrade their ...
If Inter Miami CF needed any extra motivation in Leagues Cup 2025, they got it from some familiar faces on Thursday night.
Fierce Pharma Asia—GSK's massive Hengrui deal; Takeda's revenue drop; Celltrion's major US plant buy
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...
Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...
DayOne, a Singapore-based global data center developer and operator, and Gaw Capital Partners, a multi-asset investment management firm focusing on real estate, growth equity, private credit, and ...
Q2 2025 Earnings Call August 1, 2025 10:00 AM ETCompany ParticipantsArmin Jahangiri - Senior VP & COODale Lewko ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results